Trial Profile
Brain histamine H1 receptor occupancy of newly-marketed non-sedating antihistamines: PET measurement in normal volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2023
Price :
$35
*
At a glance
- Drugs Fexofenadine (Primary) ; Levocetirizine (Primary)
- Indications Allergic rhinitis; Dermatitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis; Urticaria
- Focus Pharmacodynamics
- 20 Apr 2015 Status changed from recruiting to completed, according to University Hospital Medical Information Network - Japan
- 06 Mar 2012 New trial record